Log in to save to my catalogue

Immunosuppressive Therapy Mitigates Immunological Rejection of Human Embryonic Stem Cell Xenografts

Immunosuppressive Therapy Mitigates Immunological Rejection of Human Embryonic Stem Cell Xenografts

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1073_pnas_0805802105

Immunosuppressive Therapy Mitigates Immunological Rejection of Human Embryonic Stem Cell Xenografts

About this item

Full title

Immunosuppressive Therapy Mitigates Immunological Rejection of Human Embryonic Stem Cell Xenografts

Publisher

United States: National Academy of Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2008-09, Vol.105 (35), p.12991-12996

Language

English

Formats

Publication information

Publisher

United States: National Academy of Sciences

More information

Scope and Contents

Contents

Given their self-renewing and pluripotent capabilities, human embryonic stem cells (hESCs) are well poised as a cellular source for tissue regeneration therapy. However, the host immune response against transplanted hESCs is not well characterized. In fact, controversy remains as to whether hESCs have immune-privileged properties. To address this i...

Alternative Titles

Full title

Immunosuppressive Therapy Mitigates Immunological Rejection of Human Embryonic Stem Cell Xenografts

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_1073_pnas_0805802105

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1073_pnas_0805802105

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

DOI

10.1073/pnas.0805802105

How to access this item